Generic name: adalimumab [ AY-da-LIM-ue-mab ]
Brand names: Humira, Humira Pen, Humira Pen Crohns/UlcerColit/HidraSuppur, Humira Pen Psoriasis/Uveitis Starter Package, Humira Pediatric, ... show all 11 brands Humira Pediatric Crohn's Disease Prefill Syringe Start Pack, Humira Pre-filled Syringe, Humira Pen Psoriasis/Uveitis/Adol HidraSuppur Starter Pack, Humira Pen Crohns/Ulcer Colitis/Hidradenitis Suppurati StrPk, Humira Pen Psoriasis/Uveitis Starter Pack, Humira Pen Pediatric Ulcerative Colitis Starter Pack
Dosage form: subcutaneous kit (10 mg/0.1 mL; 20 mg/0.2 mL; 40 mg/0.4 mL; 40 mg/0.8 mL; 80 mg/0.8 mL; 80 mg/0.8 mL-40 mg/0.4 mL)
Drug classes: Antirheumatics, TNF alfa inhibitors
What is adalimumab?
Adalimumab reduces the effects of a substance in the body that can cause inflammation.
Adalimumab is used to treat many inflammatory conditions in adults, such as ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Adalimumab may also be used for purposes not listed in this medication guide.
adalimumab affects your immune system. You may get infections more easily, even serious or fatal infections.
Before or during treatment with adalimumab, tell your doctor if you have signs of infection such as fever, chills, aches, tiredness, cough, skin sores, diarrhea, or burning when you urinate.
Before taking this medicine
Before you start using adalimumab, tell your doctor if you have signs of infection--fever, chills, sweats, muscle aches, tiredness, cough, bloody mucus, skin sores, diarrhea, burning when you urinate, or feeling constantly tired.
Adalimumab should not be given to a child younger than 2 years old (or 6 years old if treating Crohn's disease). Children using adalimumab should be current on all childhood immunizations before starting treatment.
Tell your doctor if you have ever had:
tuberculosis (or if anyone in your household has tuberculosis);
a chronic infection;
hepatitis B (adalimumab can cause hepatitis B to come back or get worse);
an allergy to latex rubber;
if you are scheduled to have major surgery; or
if you have recently received or are scheduled to receive any vaccine.
Tell your doctor where you live and if you have recently traveled or plan to travel. You may be exposed to infections that are common to certain areas of the world.
Adalimumab may cause a rare type of lymphoma (cancer) of the liver, spleen, and bone marrow that can be fatal. This has occurred mainly in teenagers and young men with Crohn's disease or ulcerative colitis. However, anyone with an inflammatory autoimmune disorder may have a higher risk of lymphoma. Talk with your doctor about your own risk.
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant. Make sure any doctor caring for your newborn baby knows if you used adalimumab while you were pregnant.
It may not be safe to breastfeed a baby while you are using this medicine. Ask your doctor about any risks.
How should I use adalimumab?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Adalimumab is injected under the skin. A healthcare provider will teach you how to properly use adalimumab by yourself.
Do not start using adalimumab if you have any signs of an infection. Call your doctor for instructions.
Do not use adalimumab if you do not understand the instructions for proper use. Ask your doctor or pharmacist if you have any questions.
The dose schedule for adalimumab is highly variable and depends on the condition you are treating. Follow your doctor's dosing instructions very carefully.
Prepare your injection only when you are ready to give it. Do not use if the medicine looks cloudy, has changed color, or has particles in it. Call your pharmacist for new medicine.
Adalimumab affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.
Store this medicine in its original carton in a refrigerator. Do not freeze. If you are traveling, carefully follow all patient instructions for storing your medicine during travel. Avoid extreme heat or cold.
Throw away any adalimumab that has become frozen.
Use a needle and syringe only once and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.
What happens if I miss a dose?
Use the medicine as soon as you remember, and then go back to your regular injection schedule. Do not use extra medicine to make up the missed dose.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while using adalimumab?
Do not inject adalimumab into skin that is bruised, red, tender, or hard.
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
Do not receive a "live" vaccine while using adalimumab. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), or zoster (shingles).
Adalimumab side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor right away if you have any symptoms of lymphoma:
fever, swollen glands, night sweats, general feeling of illness;
joint and muscle pain, skin rash, easy bruising or bleeding;
pale skin, feeling light-headed or short of breath, cold hands and feet;
pain in your upper stomach that may spread to your shoulder; or
loss of appetite, feeling full after eating only a small amount, weight loss.
Also call your doctor at once if you have:
new or worsening psoriasis (raised, silvery flaking of the skin);
a sore or bump on your skin that does not heal;
symptoms of sepsis--confusion, chills, severe drowsiness, fast heartbeats, rapid breathing, feeling very ill;
lupus-like syndrome--joint pain or swelling, chest pain, shortness of breath, patchy skin color that worsens in sunlight;
nerve problems--numbness, tingling, dizziness, vision problems, weakness in your arms or legs; or
signs of tuberculosis--fever with ongoing cough, weight loss (fat or muscle).
Older adults may be more likely to develop infections or cancer while using adalimumab.
Common side effects of adalimumab may include:
redness, bruising, itching, or swelling where the injection was given.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What other drugs will affect adalimumab?
Some drugs should not be used together with adalimumab. Tell your doctor about all medicines you use, and those you start or stop using during your treatment with adalimumab, especially:
This list is not complete. Other drugs may interact with adalimumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
You can take Humira with an antibiotic if your doctor has prescribed both of these medications for you. There may be some antibiotics that are not safe to take with Humira, so do not start taking any antibiotic without prior approval from your doctor. Continue reading
Both Cosentyx and Humira are subcutaneous injections (SC - given under the skin) that may be used to treat certain inflammatory conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. After an initial loading dose, Humira is given every two weeks and Cosentyx every four weeks. Both are biologics and are made from immune system cells, but reduce inflammation in different ways. Humira contains adalimumab and reduces inflammation by blocking the action of TNF-alfa (a signaling protein [also called a cytokine)] whereas Cosentyx contains secukinumab and works by stopping interleukin 17A from binding to the IL-17 receptor. For people with psoriasis, Humira is only approved for adults but Cosentyx may be used in adults and children over the age of 6. No differences in effectiveness were found in a head-to-head trial comparing Cosentyx to Humira for psoriatic arthritis. Continue reading
In a head-to-head clinical study between Skyrizi and Humira, researchers found that Skyrizi was better than Humira at clearing moderate-to-severe plaque psoriasis in adults. At 16 weeks, 72% of patients given Skyrizi achieved 90% clearer skin compared to 47% of patients given Humira, a statistically significant outcome. Continue reading
- What are the new drugs for the treatment of rheumatoid arthritis (RA)?
- What are the new drugs for the treatment of plaque psoriasis?
- How many biosimilars have been approved in the United States?
More about adalimumab
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (658)
- En español
- Drug class: antirheumatics
- Advanced Reading
- Adalimumab-adaz Subcutaneous (Advanced Reading)
- Adalimumab-adbm Subcutaneous (Advanced Reading)
- Adalimumab-afzb Subcutaneous (Advanced Reading)
- Adalimumab-aqvh Subcutaneous (Advanced Reading)
Related treatment guides
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2022 Cerner Multum, Inc. Version: 14.02.